Bing

The stock has a consensus rating of Buy and an average price target ... The Firm’s generic pharmaceutical business is conducted primarily in America and Canada (NASDAQ:MYL); Europe, the Middle East, and …
Mideast Times · 8/21/2015
Mylan NV
Spreads have also widened attractively for Mylan NV's (MYL) offer for Perrigo Co. plc (PRGO ... On Wednesday investors pushed to rally U.S. stocks amid the worst drop in global equities in almost four years but …
The Deal Pipeline · 8/27/2015
market volatility
They also point out that, depending on the results, there is the potential for meaningful stock moves. Here are two of the catalysts we picked that the RBC analysts take a close look at. Mylan N.V. (NYSE: MYL) has a shareholder vote coming up next week …
24/7 Wall ST · 8/20/2015
MYL) are scheduled to vote on whether to approve a $30-billion-plus hostile takeover bid for Perrigo and move ahead with a tender offer. Perrigo has rejected the offer as undervaluing the company. Shareholders also …
jewocity.com · 1 day ago
marking the fourth consecutive day the stock has increased. Mylan Inc (MYL): MYL stock is up 1.5% today. Examworks Group (EXAM): EXAM stock is up 0.3% today. Fresenius Medical Care Corp (FMS): FMS stock is up 0.2% today on 3 times normal …
Investor Place · 8/6/2015
Mylan (NASDAQ:MYL), a company whose shares are moving quickly ... on a current price of $51.52 and an average consensus analyst price target of $72.75. The stock should find initial resistance at its 200-day moving average (MA) of $61.96 and further ...
Financial News Network Online · ByRobert Cotter · 8/25/2015
Mylan N.V. (MYL) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at MYL given that, according to its RSI reading of 26.62 ...
Yahoo Finance · 8/14/2015
Investors are always looking for stocks that are poised to beat at earnings season and Mylan N.V. ( (MYL - Analyst Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
ZACKS · 8/5/2015
Mylan (MYL.O) shareholders are set to vote on Friday on whether the company should move forward with the Perrigo bid, whose value has declined with the recent market sell-off. If more than half vote "yes," Mylan plans to take its cash and stock offer ...
Reuters · ByBill Berkrot · 8/25/2015
and the inflated value of MYL stock. We note that any acquisition made by PRGO during the current “offer period” is subject to approval by the Irish Takeover Panel (and potential shareholder approval as well). Perrigo has rebuffed bids from Mylan ...
Barron's · ByJohanna Bennett · 6/30/2015

Mylan

Company
Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters …
Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands and with operational headquarters in Hatfield, Hertfordshire in the United Kingdom. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, Mylan has grown from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. Mylan now has approximately 30,000 employees, more than 1,000 separate products, and serves customers in more than 150 countries and territories. Mylan has a global manufacturing output of more than 45 billion doses.
Data from: Wikipedia · Freebase